Serum angiopoietin-like protein 3 levels: Possible correlation with progressive skin sclerosis, digital ulcers and pulmonary vascular involvement in patients with systemic sclerosis

Acta Dermato-Venereologica

Volumn 94, Issue 2, 2014, Pages 157-162

  Ichimura, Yohei ^a   Asano, Yoshihide ^a   Akamata, Kaname ^a   Aozasa, Naohiko ^a   Noda, Shinji ^a   Taniguchi, Takashi ^a   Takahashi, Takehiro ^a   Toyama, Tetsuo ^a   Sumida, Hayakazu ^a   Kuwano, Yoshihiro ^a   Yanaba, Koichi ^a   Tada, Yayoi ^a   Sugaya, Makoto ^a   Sato, Shinichi ^a   Kadono, Takafumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiogenesis; Angiopoietin like protein 3; Digital ulcers; Pulmonary arterial hypertension; Skin sclerosis; Systemic sclerosis

Indexed keywords

ADULT; AGED; ANGIOPOIETINS; BLOOD PRESSURE; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FINGERS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SKIN ULCER; SYSTOLE; VENTRICULAR FUNCTION, RIGHT;

EID: 84894048965     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1680     Document Type: Article

References (22)

1. Asano Y. Future treatments in systemic sclerosis. J Dermatol 2010; 37: 54-70.
2. Hato T, Tabata M, Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc Med 2008; 18: 6-14.
3. Conklin D, Gilbertson D, Taft DW, Maurer MF, Whitmore TE, Smith DL, et al. Identification of a mammalian angiopoietin-related protein expressed specifically in liver. Genomics 1999; 62: 477-482.
4. Koishi R, Ando Y, Ono M, Shimamura M, Yasumo H, Fujiwara T, et al. Angptl3 regulates lipid metabolism in mice. Nat Genet 2002; 30: 151-157.
5. Ono M, Shimizugawa T, Shimamura M, Yoshida K, Noji-Sakikawa C, Ando Y, et al. Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo. J Biol Chem 2003; 278: 41804-41809.
6. Camenisch G, Pisabarro MT, Sherman D, Kowalski J, Nagel M, Hass P, et al. ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. J Biol Chem 2002; 277: 17281-17290.
7. Hatsuda S, Shoji T, Shinohara K, Kimoto E, Mori K, Fukumoto S, et al. Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subjects. J Vasc Res 2007; 44: 61-66.
8. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-205.
9. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-590.
10. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993; 20: 1892-1896.
11. Kazerooni EA, Martinez FJ, Flint A, Jamadar DA, Gross BH, Spizarny DL, et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. Am J Roentgenol 1997; 169: 977-983.
12. Steen VD, Medsger TA, Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000; 43: 2437-2444.
13. Marvi U, Chung L. Digital ischemic loss in systemic sclerosis. Int J Rheumatol 2010; 2010.
14. Shimizugawa T, Ono M, Shimamura M, Yoshida K, Ando Y, Koishi R, et al. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem 2002; 277: 33742-33748.
15. Shimamura M, Matsuda M, Kobayashi S, Ando Y, Ono M, Koishi R, et al. Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. Biochem Biophys Res Commun 2003; 301: 604-609.
16. Ando Y, Shimizugawa T, Takeshita S, Ono M, Shimamura M, Koishi R, et al. A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice. J Lipid Res 2003; 44: 1216-1223.
17. Korstanje R, Eriksson P, Samnegård A, Olsson PG, Forsman-Semb K, Sen S, et al. Locating Ath8, a locus for murine atherosclerosis susceptibility and testing several of its candidate genes in mice and humans. Atherosclerosis 2004; 177: 443-450.
18. Bhardwaj S, Roy H, Heikura T, Ylä-Herttuala S. VEGF-A, VEGF-D and VEGF-D(DNDC) induced intimal hyperplasia in carotid arteries. Eur J Clin Invest 2005; 35: 669-676.
19. Horn A, Distler JH. Vascular alterations upon activation of TGFb signaling in fibroblasts - implications for systemic sclerosis. Arthritis Res Ther 2010; 12: 125.
20. Kowal-Bielecka O, Avouac J, Pittrow D, Huscher D, Behrens F, Denton CP, et al. Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group. J Rheumatol 2010; 37: 105-115.
21. Michalska-Jakubus M, Kowal-Bielecka O, Chodorowska G, Bielecki M, Krasowska D. Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease. Rheumatology (Oxford) 2011; 50: 746-755.
22. Dunne JV, Keen KJ, Van Eeden SF. Circulating angiopoietin and Tie-2 levels in systemic sclerosis. Rheumatol Int 2013; 33: 475-484.